ResMed (RMD) Misses Q1 EPS by 2c

October 25, 2016 4:12 PM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

ResMed (NYSE: RMD) reported Q1 EPS of $0.62, $0.02 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $465.4 million versus the consensus estimate of $474.73 million.

For earnings history and earnings-related data on ResMed (RMD) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment